Int J Heart Fail.
2024 Jan;6(1):44-45. 10.36628/ijhf.2024.0002.
Is It Time to Expand the Indication of DOAC to Patients With Cardiac Amyloidosis and Atrial Fibrillation?
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
- 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
- KMID: 2552037
- DOI: http://doi.org/10.36628/ijhf.2024.0002
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Direct Oral Anticoagulants in Patients With Cardiac Amyloidosis: A Systematic Review and Meta-Analysis
- Hemoptysis in Quadriplegia with Atrial Fibrillation Who Was Taking Edoxaban: a Case Report
- Pharmacological Treatment of Atrial Fibrillation
- How and When to Screen for Atrial Fibrillation after Stroke: Insights from Insertable Cardiac Monitoring Devices
- Drug Utilization of Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation in the Elderly
